Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases (Q3696479): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q2536134 / rank | |||
Normal rank | |||
Revision as of 18:25, 24 November 2021
Project Q3696479 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases |
Project Q3696479 in France |
Statements
15,500.0 Euro
0 references
32,000.0 Euro
0 references
48.44 percent
0 references
1 September 2015
0 references
31 December 2016
0 references
Université de Lorraine
0 references
Mise en place d’un traitement chronique préventif, basé sur l’administration orale de S-nitrosothiols (RSNO (French)
0 references
Introduction of chronic preventive treatment based on oral administration of S-nitrosothiols (RSNO) (English)
22 November 2021
0 references
Identifiers
LO0006484
0 references